
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $13.3M | $9.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -31.72% | |
Cost of Revenues | -- | -- | -- | $1.5M | $2.4M | |
Gross Profit | -- | -- | -- | $11.8M | $6.7M | |
Gross Profit Margin | -- | -- | -- | 88.47% | 73.75% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | $2.1M | $2.1M | |
Other Inc / (Exp) | -- | -- | -- | $494.8K | -$7.3K | |
Operating Expenses | -- | -- | -- | $10.7M | $7.8M | |
Operating Income | -- | -- | -- | $1.1M | -$1.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | $1.8M | $176K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $332K | $44.7K | |
Net Income to Company | -- | -- | -- | $1.5M | $131.3K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | $1.5M | $131.3K | |
Basic EPS (Cont. Ops) | -- | -- | -- | $7.53 | $0.67 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | $7.53 | $0.67 | |
Weighted Average Basic Share | -- | -- | -- | $196.4K | $196.4K | |
Weighted Average Diluted Share | -- | -- | -- | $196.4K | $196.4K | |
EBITDA | -- | -- | -- | $1.9M | $287.8K | |
EBIT | -- | -- | -- | $1.9M | $259.2K | |
Revenue (Reported) | -- | -- | -- | $13.3M | $9.1M | |
Operating Income (Reported) | -- | -- | -- | $1.1M | -$1.1M | |
Operating Income (Adjusted) | -- | -- | -- | $1.9M | $259.2K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $1.3M | $2.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | 100.14% | |
Cost of Revenues | -- | -- | -- | $455.7K | $435.3K | |
Gross Profit | -- | -- | -- | $815K | $2.1M | |
Gross Profit Margin | -- | -- | -- | 64.14% | 82.88% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | $907.8K | $13.1M | $1.1M | |
Other Inc / (Exp) | -- | -- | $61.5K | -$74.8M | $114.5K | |
Operating Expenses | -- | -- | $907.8K | $14.6M | $3.1M | |
Operating Income | -- | -- | -$907.8K | -$13.8M | -$1M | |
Net Interest Expenses | -- | -- | -- | -- | $2.3M | |
EBT. Incl. Unusual Items | -- | -- | $455.2K | -$88.6M | -$3.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $262.8K | -$6K | -$304.2K | |
Net Income to Company | -- | -- | -- | -$88.6M | -$2.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | $192.4K | -$88.6M | -$2.9M | |
Basic EPS (Cont. Ops) | -- | -- | $0.98 | -$471.60 | -$1.25 | |
Diluted EPS (Cont. Ops) | -- | -- | $0.98 | -$471.60 | -$1.25 | |
Weighted Average Basic Share | -- | -- | $196.4K | $150.8K | $2.3M | |
Weighted Average Diluted Share | -- | -- | $196.4K | $150.8K | $2.3M | |
EBITDA | -- | -- | $455.2K | -$87.6M | -$89.2K | |
EBIT | -- | -- | $455.2K | -$88.1M | -$441.9K | |
Revenue (Reported) | -- | -- | -- | $1.3M | $2.5M | |
Operating Income (Reported) | -- | -- | -$907.8K | -$13.8M | -$1M | |
Operating Income (Adjusted) | -- | -- | $455.2K | -$88.1M | -$441.9K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $10.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | $2.5M | |
Gross Profit | -- | -- | -- | -- | $8.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | $3.8M | |
Other Inc / (Exp) | -- | -- | $61.5K | -$74.9M | -$13.6M | |
Operating Expenses | -- | -- | -- | -- | $11.6M | |
Operating Income | -- | -- | -- | -- | -$3.3M | |
Net Interest Expenses | -- | -- | -- | -- | $8.1M | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -$25.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -$931.6K | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$24.2M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$184.73 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$250.39 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -$13.7M | |
EBIT | -- | -- | -- | -- | -$15M | |
Revenue (Reported) | -- | -- | -- | -- | $10.8M | |
Operating Income (Reported) | -- | -- | -- | -- | -$3.3M | |
Operating Income (Adjusted) | -- | -- | -- | -- | -$15M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | $1.3M | $2.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | $455.7K | $435.3K | |
Gross Profit | -- | -- | -- | $815K | $2.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | $907.8K | $13.1M | $1.1M | |
Other Inc / (Exp) | -- | -- | $61.5K | -$74.8M | $114.5K | |
Operating Expenses | -- | -- | $907.8K | $14.6M | $3.1M | |
Operating Income | -- | -- | -$907.8K | -$13.8M | -$1M | |
Net Interest Expenses | -- | -- | -- | -- | $2.3M | |
EBT. Incl. Unusual Items | -- | -- | $455.2K | -$88.6M | -$3.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $262.8K | -$6K | -$304.2K | |
Net Income to Company | -- | -- | -- | -$88.6M | -$2.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | $192.4K | -$88.6M | -$2.9M | |
Basic EPS (Cont. Ops) | -- | -- | $0.98 | -$471.60 | -$1.25 | |
Diluted EPS (Cont. Ops) | -- | -- | $0.98 | -$471.60 | -$1.25 | |
Weighted Average Basic Share | -- | -- | $196.4K | $150.8K | $2.3M | |
Weighted Average Diluted Share | -- | -- | $196.4K | $150.8K | $2.3M | |
EBITDA | -- | -- | $455.2K | -$87.6M | -$89.2K | |
EBIT | -- | -- | $455.2K | -$88.1M | -$441.9K | |
Revenue (Reported) | -- | -- | -- | $1.3M | $2.5M | |
Operating Income (Reported) | -- | -- | -$907.8K | -$13.8M | -$1M | |
Operating Income (Adjusted) | -- | -- | $455.2K | -$88.1M | -$441.9K |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $129.6K | $619.6K | |
Short Term Investments | -- | -- | -- | $204M | $54.8M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | $33.7K | $58.8K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | -- | $204.2M | $55.5M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | $204.2M | $55.5M | |
Accounts Payable | -- | -- | -- | $4.8M | $5.5M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | $1.4M | |
Total Current Liabilities | -- | -- | -- | $5.6M | $12.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $5.8M | $12.4M | |
Common Stock | -- | -- | -- | $500 | $500 | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | $198.4M | $43.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | $198.4M | $43.1M | |
Total Liabilities and Equity | -- | -- | -- | $204.2M | $55.5M | |
Cash and Short Terms | -- | -- | -- | $204.2M | $55.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | $7.2M | $7.8M | |
Short Term Investments | -- | -- | -- | $60 | $50 | |
Accounts Receivable, Net | -- | -- | -- | $687.9K | $396.2K | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | $245.7K | $848.7K | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | -- | $32.1M | $29.7M | |
Property Plant And Equipment | -- | -- | -- | $389.6K | $216.1K | |
Long-Term Investments | -- | -- | -- | $91.2K | $43.7K | |
Goodwill | -- | -- | -- | -- | $6.1M | |
Other Intangibles | -- | -- | -- | $38.1M | $15.1M | |
Other Long-Term Assets | -- | -- | -- | $5.8M | $333.5K | |
Total Assets | -- | -- | -- | $76.4M | $55M | |
Accounts Payable | -- | -- | -- | $25.7M | $23M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | $13.7M | $10.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | $159.9K | $118.5K | |
Other Current Liabilities | -- | -- | -- | -- | $3.4M | |
Total Current Liabilities | -- | -- | -- | $46.7M | $42M | |
Long-Term Debt | -- | -- | -- | $9.2M | $11.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | $80.4M | $69M | |
Common Stock | -- | -- | -- | $1.2K | $620 | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -$4.1M | -$14M | |
Total Liabilities and Equity | -- | -- | -- | $76.4M | $55M | |
Cash and Short Terms | -- | -- | -- | $7.2M | $7.8M | |
Total Debt | -- | -- | -- | $25.4M | $22.8M |
Period Ending | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | $1.5M | $131.3K | |
Depreciation & Amoritzation | -- | -- | -- | $37.2K | $28.5K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | $23.1M | $1.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$5.2M | -$23.1M | |
Capital Expenditures | -- | -- | -- | $13.8K | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$16K | -$2.1K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$41K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -$41K | |
Beginning Cash (CF) | -- | -- | -- | $64.4M | $59.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$5.2M | -$23.2M | |
Ending Cash (CF) | -- | -- | -- | $59.2M | $36.1M | |
Levered Free Cash Flow | -- | -- | -- | -$5.2M | -$23.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$88.6M | -$2.9M | |
Depreciation & Amoritzation | -- | -- | -- | $456.5K | $352.6K | |
Stock-Based Compensation | -- | -- | -- | $1.5M | $39.4K | |
Change in Accounts Receivable | -- | -- | -- | $92.1K | $588.5K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$13.3M | -$1.8M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | $33M | -- | |
Cash From Investing | -- | -- | -- | $81M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $6M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$56.5K | |
Repurchase of Common Stock | -- | -- | -- | -$53.9M | -- | |
Other Financing Activities | -- | -- | -- | $7.3M | $904K | |
Cash From Financing | -- | -- | -- | -$40.7M | $847.5K | |
Beginning Cash (CF) | -- | -- | -- | $619.6K | $28.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $26.9M | -$967.9K | |
Ending Cash (CF) | -- | -- | -- | $27.6M | $27.5M | |
Levered Free Cash Flow | -- | -- | -- | -$13.3M | -$1.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | $1.5M | $42K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | $33M | -$125K | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -$14.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$88.6M | -$2.9M | |
Depreciation & Amoritzation | -- | -- | -- | $456.5K | $352.6K | |
Stock-Based Compensation | -- | -- | -- | $1.5M | $39.4K | |
Change in Accounts Receivable | -- | -- | -- | $92.1K | $588.5K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$13.3M | -$1.8M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | $33M | -- | |
Cash From Investing | -- | -- | -- | $81M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $6M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$56.5K | |
Repurchase of Common Stock | -- | -- | -- | -$53.9M | -- | |
Other Financing Activities | -- | -- | -- | $7.3M | $904K | |
Cash From Financing | -- | -- | -- | -$40.7M | $847.5K | |
Beginning Cash (CF) | -- | -- | -- | $619.6K | $28.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $26.9M | -$967.9K | |
Ending Cash (CF) | -- | -- | -- | $27.6M | $27.5M | |
Levered Free Cash Flow | -- | -- | -- | -$13.3M | -$1.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.